Academic Publications

Read academic publications and research articles on living kidney donation and kidney matching technology.

Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes

October 1, 2024January 2, 2025Frontiers in Genetics

Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes: Read More

Long-Term Survival after Kidney Transplantation

August 19, 2021May 4, 2022The New England Journal of Medicine

Long-Term Survival after Kidney Transplantation: Read More

Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study

November 1, 2020May 4, 2022Journal of the American Society of Nephrology

Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study: Read More

Adequate Tacrolimus Exposure Modulates the Impact of HLA Class II Molecular Mismatch: A Validation Study in an American Cohort

September 4, 2020May 4, 2022American Journal of Transplantation

Adequate Tacrolimus Exposure Modulates the Impact of HLA Class II Molecular Mismatch: A Validation Study in an American Cohort: Read More

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity

November 4, 2018May 4, 2022American Journal of Transplantation

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity: Read More

Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation

December 1, 2017May 4, 2022American Journal of Transplantation

Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation: Read More

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development

May 15, 2017May 4, 2022Journal of the American Society of Nephrology

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development: Read More